Search Within

Sean McCarthy Devlin

  1. "2021"
Formats
  1. Journal Article (24)
  2. Meeting Abstract (8)
  3. Research Letter (4)
Groups
  1. Biostatistics Service (36)
  2. Epidemiology and Biostatistics (36)
  3. Center for Hematologic Malignancies (33)
  4. Department of Medicine (33)
  5. Hematologic Malignancies, Division of (33)
  6. Bone Marrow Transplant (28)

More Groups

People
  1. Sergio Giralt (23)
  2. Miguel-Angel Perales (19)
  3. Gunjan Shah (14)
  4. Molly Maloy (11)
  5. Parastoo Dahi (11)
  6. Craig Sauter (10)

More People

Years
  1. 2021 (36)
Publications
  1. Blood (9)
  2. Transplantation and Cellular Therapy (6)
  3. Blood Advances (4)
  4. American Journal of Hematology (2)
  5. Blood Cancer Discovery (2)
  6. Haematologica (2)

More Publications

Publishers
  1. American Society of Hematology (13)
  2. Elsevier Inc. (6)
  3. Nature Publishing Group (4)
  4. American Association for Cancer Research (3)
  5. Ferrata Storti Foundation (2)
  6. John Wiley & Sons, Inc. (2)

More Publishers

Results (36)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Post-transplant cyclophosphamide is associated with improved clinical outcomes in HLA-mismatched unrelated donor hematopoietic cell transplantation
    Meeting Abstract

    Jimenez, A. M.; Perales, M. A.; Devlin, S. M.; Lekakis, L. J.; Sauter, C. S.; Pereira, D.; Beitinjaneh, A.; Brown, S.; Wang, T.; Ponce, D. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Timing and immune status after cellular therapies predict response to COVID-19 vaccines
    Meeting Abstract

    Tamari, R.; Politikos, I.; Knorr, D.; Vardhana, S.; Young, J.; Marcello, L.; Doddi, S.; Devlin, S. M.; Ramanathan, L.; Pessin, M. S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • The intestinal microbiota correlates with response and toxicity after CAR T cell therapy in patients with B-cell malignancies
    Meeting Abstract

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Daratumumab versus lenalidomide maintenance therapy for multiple myeloma: A randomized pilot study comparing patient-reported health related quality of life measures
    Meeting Abstract

    Shah, U. A.; Malik, M.; Werner, K.; Burge, M.; Devlin, S. M.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Tan, C.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Nutrition as a predictor of microbiome injury in allo-HCT
    Meeting Abstract

    Dai, A.; Adintori, P. A.; Docampo, M. D.; Brambilla, C. Z.; Buchan, M. L.; Gomes, A. L.; Burgos da Silva, M. D.; Markey, K. A.; Devlin, S. M.; Clurman, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • MAIT and Vδ2 unconventional T cells predict favorable outcome after allogeneic HCT and are supported by a diverse intestinal microbiome
    Meeting Abstract

    Andrlova, H.; Miltiadous, O.; Dai, A.; Gardner, R.; El Daker, S.; Slingerland, J. B.; Giardina, P. A.; Clurman, A.; Gomes, A. L. C.; Nguyen, C. L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Identifying prognostic pairwise relationships among bacterial species in microbiome studies
    Journal Article

    Devlin, S. M.; Martin, A.; Ostrovnaya, I.
    PLoS Computational Biology (2021)

    Fulltext@MSK | Save
  • Using mobile wearables to establish sleep bioprofiles in newly diagnosed multiple myeloma (MM) patients
    Meeting Abstract

    Hevroni, G.; Mastey, D.; Tavitian, E.; Derkach, A.; Salcedo, M.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Hultcrantz, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Oral proteasome inhibitor ixazomib for switch-maintenance prophylaxis of recurrent or late acute and chronic graft-versus-host disease after day 100 in allogeneic stem cell transplantation
    Journal Article

    Rodriguez, N.; Lee, J.; Flynn, L.; Murray, F.; Devlin, S. M.; Soto, C.; Cho, C.; Dahi, P.; Giralt, S.; Perales, M. A.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save